CStone Pharmaceuticals Statistics

Total Valuation

HKG:2616 has a market cap or net worth of HKD 6.04 billion. The enterprise value is 5.65 billion.

Market Cap	6.04B
Enterprise Value	5.65B

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2616 has 1.36 billion shares outstanding. The number of shares has increased by 1.04% in one year.

Current Share Class	1.36B
Shares Outstanding	1.36B
Shares Change (YoY)	+1.04%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	1.58%
Owned by Institutions (%)	9.46%
Float	926.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.94
PB Ratio	15.60
P/TBV Ratio	28.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-58.23
EV / Sales	13.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.98.

Current Ratio	1.60
Quick Ratio	1.18
Debt / Equity	0.98
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.29

Financial Efficiency

Return on equity (ROE) is -22.23% and return on invested capital (ROIC) is -7.74%.

Return on Equity (ROE)	-22.23%
Return on Assets (ROA)	-3.90%
Return on Invested Capital (ROIC)	-7.74%
Return on Capital Employed (ROCE)	-13.40%
Revenue Per Employee	3.21M
Profits Per Employee	-718,963
Employee Count	135
Asset Turnover	0.27
Inventory Turnover	0.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +315.89% in the last 52 weeks. The beta is 0.14, so HKG:2616's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+315.89%
50-Day Moving Average	3.47
200-Day Moving Average	2.63
Relative Strength Index (RSI)	61.15
Average Volume (20 Days)	18,848,167

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2616 had revenue of HKD 433.34 million and -97.06 million in losses. Loss per share was -0.08.

Revenue	433.34M
Gross Profit	255.57M
Operating Income	-101.48M
Pretax Income	-97.06M
Net Income	-97.06M
EBITDA	-87.33M
EBIT	-101.48M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 766.08 million in cash and 378.82 million in debt, giving a net cash position of 387.26 million or 0.29 per share.

Cash & Cash Equivalents	766.08M
Total Debt	378.82M
Net Cash	387.26M
Net Cash Per Share	0.29
Equity (Book Value)	387.22M
Book Value Per Share	0.30
Working Capital	434.08M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-365.20M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.98%, with operating and profit margins of -23.42% and -22.40%.

Gross Margin	58.98%
Operating Margin	-23.42%
Pretax Margin	-22.40%
Profit Margin	-22.40%
EBITDA Margin	-20.15%
EBIT Margin	-23.42%
FCF Margin	n/a

Dividends & Yields

HKG:2616 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.04%
Shareholder Yield	n/a
Earnings Yield	-1.61%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2616 has an Altman Z-Score of -7.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.7
Piotroski F-Score	1